| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Respiratory Division, McGill University Health Centre, and Meakins-Christie Laboratories, McGill University, Montreal H3A 1A1
2 Neuromuscular Research Group, Montreal Neurological Institute, McGill University, Montreal H3A 2B4
3 Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec, Canada H4P 2R2
Ebihara, Satoru, Ghiabe-Henri Guibinga, Renald Gilbert, Josephine Nalbantoglu, Bernard Massie, George Karpati, and Basil J. Petrof. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiol Genomics 3: 133–144, 2000.—Duchenne muscular dystrophy (DMD) is a fatal disease caused by defects in the gene encoding dystrophin. Dystrophin is a cytoskeletal protein, which together with its associated protein complex, helps to protect the sarcolemma from mechanical stresses associated with muscle contraction. Gene therapy efforts aimed at supplying a normal dystrophin gene to DMD muscles could be hampered by host immune system recognition of dystrophin as a "foreign" protein. In contrast, a closely related protein called utrophin is not foreign to DMD patients and is able to compensate for dystrophin deficiency when overexpressed throughout development in transgenic mice. However, the issue of which of the two candidate molecules is superior for DMD therapy has remained an open question. In this study, dystrophin and utrophin gene transfer effects on dystrophic muscle function were directly compared in the murine (mdx) model of DMD using E1/E3-deleted adenovirus vectors containing either a dystrophin (AdV-Dys) or a utrophin (AdV-Utr) transgene. In immunologically immature neonatal animals, AdV-Dys and AdV-Utr improved tibialis anterior muscle histopathology, force-generating capacity, and the ability to resist injury caused by high-stress contractions to an equivalent degree. By contrast, only AdV-Utr was able to achieve significant improvement in force generation and the ability to resist stress-induced injury in the soleus muscle of immunocompetent mature mdx animals. In addition, in mature mdx mice, there was significantly greater transgene persistence and reduced inflammation with utrophin compared to dystrophin gene transfer. We conclude that dystrophin and utrophin are largely equivalent in their intrinsic abilities to prevent the development of muscle necrosis and weakness when expressed in neonatal mdx animals with an immature immune system. However, because immunity against dystrophin places an important limitation on the efficacy of dystrophin gene replacement in an immunocompetent mature host, the use of utrophin as an alternative to dystrophin gene transfer in this setting appears to offer a significant therapeutic advantage.
Duchenne/Becker muscular dystrophy; gene therapy; viral vectors; host immunity; muscle mechanics
This article has been cited by other articles:
|
|
 |
|
  K. Hnia, J. Gayraud, G. Hugon, M. Ramonatxo, S. De La Porte, S. Matecki, and D. Mornet L-Arginine Decreases Inflammation and Modulates the Nuclear Factor-{kappa}B/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers Am. J. Pathol., June 1, 2008; 172(6): 1509 - 1519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okazaki, S. Ebihara, M. Asada, S. Yamanda, Y. Saijo, Y. Shiraishi, T. Ebihara, K. Niu, H. Mei, H. Arai, et al. Macrophage Colony-Stimulating Factor Improves Cardiac Function after Ischemic Injury by Inducing Vascular Endothelial Growth Factor Production and Survival of Cardiomyocytes Am. J. Pathol., October 1, 2007; 171(4): 1093 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stupka, D. R. Plant, J. D. Schertzer, T. M. Emerson, R. Bassel-Duby, E. N. Olson, and G. S. Lynch Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice J. Physiol., September 1, 2006; 575(2): 645 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matecki, R. W. R. Dudley, M. Divangahi, R. Gilbert, J. Nalbantoglu, G. Karpati, and B. J. Petrof Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L569 - L576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bonuccelli, F. Sotgia, W. Schubert, D. S. Park, P. G. Frank, S. E. Woodman, L. Insabato, M. Cammer, C. Minetti, and M. P. Lisanti Proteasome Inhibitor (MG-132) Treatment of mdx Mice Rescues the Expression and Membrane Localization of Dystrophin and Dystrophin-Associated Proteins Am. J. Pathol., October 1, 2003; 163(4): 1663 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gilbert, R. W. R. Dudley, A.-B. Liu, B. J. Petrof, J. Nalbantoglu, and G. Karpati Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin Hum. Mol. Genet., June 1, 2003; 12(11): 1287 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Chamberlain Gene therapy of muscular dystrophy Hum. Mol. Genet., October 1, 2002; 11(20): 2355 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Skog, Y.-F. Mei, and G. Wadell Human adenovirus serotypes 4p and 11p are efficiently expressed in cell lines of neural tumour origin J. Gen. Virol., June 1, 2002; 83(6): 1299 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle Physiol Rev, April 1, 2002; 82(2): 291 - 329. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
